Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,680 shares at $6.42 ($10K) on 2019-06-13, disclosed to the SEC on 2019-07-26.
Open-market purchase of $10k CPIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.42 | 60 | $385 | 3.7% |
| 2 | $6.37 | 60 | $382 | 3.7% |
| 3 | $6.33 | 60 | $380 | 3.6% |
| 4 | $6.36 | 60 | $382 | 3.6% |
| 5 | $6.35 | 60 | $381 | 3.6% |
| 6 | $6.33 | 60 |
| $380 |
| 3.6% |
| 7 | $6.34 | 60 | $380 | 3.6% |
| 8 | $6.54 | 60 | $392 | 3.8% |
| 9 | $6.56 | 60 | $394 | 3.8% |
| 10 | $6.54 | 60 | $392 | 3.8% |
| 11 | $6.48 | 60 | $389 | 3.7% |
| 12 | $6.49 | 60 | $389 | 3.7% |
| 13 | $6.52 | 60 | $391 | 3.7% |
| 14 | $6.49 | 60 | $389 | 3.7% |
| 15 | $6.46 | 60 | $388 | 3.7% |
| 16 | $6.49 | 60 | $389 | 3.7% |
| 17 | $6.37 | 60 | $382 | 3.7% |
| 18 | $6.15 | 60 | $369 | 3.5% |
| 19 | $6.07 | 60 | $364 | 3.5% |
| 20 | $5.93 | 60 | $356 | 3.4% |
| 21 | $6.01 | 60 | $361 | 3.4% |
| 22 | $5.85 | 60 | $351 | 3.4% |
| 23 | $5.88 | 60 | $353 | 3.4% |
| 24 | $5.85 | 60 | $351 | 3.4% |
| 25 | $5.84 | 60 | $350 | 3.3% |
| 26 | $5.69 | 60 | $341 | 3.3% |
| 27 | $5.75 | 60 | $345 | 3.3% |
| 28 | $5.93 | 60 | $356 | 3.4% |
| Total | $6.23 avg | 1,680 | $10K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |